Advisors Asset Management Inc. Cuts Holdings in Amedisys, Inc. (NASDAQ:AMED)

Advisors Asset Management Inc. lessened its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 15.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,289 shares of the health services provider’s stock after selling 235 shares during the period. Advisors Asset Management Inc.’s holdings in Amedisys were worth $124,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AMED. KBC Group NV acquired a new position in shares of Amedisys in the 3rd quarter valued at about $63,000. Innealta Capital LLC purchased a new position in Amedisys in the second quarter valued at approximately $64,000. Signaturefd LLC lifted its position in Amedisys by 88.2% during the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after buying an additional 530 shares in the last quarter. CWM LLC grew its stake in Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after buying an additional 277 shares during the period. Finally, Crossmark Global Holdings Inc. acquired a new stake in shares of Amedisys in the third quarter worth $243,000. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Stock Performance

NASDAQ:AMED opened at $91.41 on Friday. The firm’s fifty day simple moving average is $94.86 and its 200 day simple moving average is $95.64. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a twelve month low of $88.81 and a twelve month high of $98.95. The firm has a market capitalization of $2.99 billion, a price-to-earnings ratio of 36.40, a PEG ratio of 1.92 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the prior year, the firm earned $0.98 EPS. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities research analysts expect that Amedisys, Inc. will post 4.55 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.